Pacific Sage Partners LLC lifted its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 5.8% during the 4th quarter, according to the company in its most recent filing with the SEC.

Pacific Sage Partners LLC grew its holdings in shares of Meta Platforms, Inc. (NASDAQ:META – Free Report) by 1.1% in the 4th quarter, according to its most recent disclosure with the SEC.

The proposal values Sage at around $442 million. A yearslong partner of neuroscience player Sage, Biogen already owns 10.2% of the Cambridge, Massachusetts-based biotech, according to the filing.

Sage emphasised that there is no certainty the proposal from Biogen will result in a transaction. Credit: skynesher via Getty Images. Biogen has made an unsolicited offer to acquire its partner Sage ...

Sage Therapeutics last week sued partner Biogen just days after receiving an unsolicited buyout offer from the pharma for nearly $470 million, according to reporting by Bloomberg Law. The suit, filed ...

Biogen has made an unsolicited offer to acquire its partner Sage Therapeutics following a year of significant challenges for the latter. The deal, which values Sage at $7.22 per share, represents ...

Sage Geosystems and ABB will be collaborating to develop energy storage and power generation technology to support Geopressured Geothermal Systems. ABB and Sage Geosystems (Sage) have signed a ...